Features of resistance-associated substitutions after failure of multiple direct-acting antiviral regimens for hepatitis C.

Itakura, Jun; Kurosaki, Masayuki; Kakizaki, Satoru; Amano, Keisuke; Nakayama, Nobuaki; Inoue, Jun; Endo, Tetsu; Marusawa, Hiroyuki; Hasebe, Chitomi; Joko, Kouji; Wada, Shuichi; Akahane, Takehiro; Koushima, Youhei; Ogawa, Chikara; Kanto, Tatsuya; Mizokami, Masashi; Izumi, Namiki

Itakura, Jun; Kurosaki, Masayuki; Kakizaki, Satoru; Amano, Keisuke; Nakayama, Nobuaki; Inoue, Jun; Endo, Tetsu; Marusawa, Hiroyuki; Hasebe, Chitomi; Joko, Kouji; Wada, Shuichi; Akahane, Takehiro; Koushima, Youhei; Ogawa, Chikara; Kanto, Tatsuya; Mizokami, Masashi; Izumi, Namiki.

Afiliação

Itakura J; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino, Tokyo, Japan.
Kurosaki M; Japanese Red Cross liver Study Group.
Kakizaki S; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino, Tokyo, Japan.
Amano K; Japanese Red Cross liver Study Group.
Nakayama N; Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Gunma, Japan.
Inoue J; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Endo T; Department of Gastroenterology & Hepatology, Faculty of Medicine, Saitama Medical University, Iruma-Gun, Saitama, Japan.
Marusawa H; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hasebe C; Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Joko K; Japanese Red Cross liver Study Group.
Wada S; Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.
Akahane T; Japanese Red Cross liver Study Group.
Koushima Y; Department of Gastroenterology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Hokkaido, Japan.
Ogawa C; Japanese Red Cross liver Study Group.
Kanto T; Center for Liver-Biliary-Pancreatic Disease, Matsuyama Red Cross Hospital, Matsuyama, Ehime, Japan.
Mizokami M; Japanese Red Cross liver Study Group.
Izumi N; Department of Gastroenterology and Hepatology, Nagano Red Cross Hospital, Nagano, Japan.

JHEP Rep ; 2(5): 100138, 2020 Oct.

Article em En | MEDLINE | ID: mdl-32817930

Palavras-chave

ALT, alanine aminotransferase; AST, aspartate transaminase; ASV, asunaprevir; BCV, beclabuvir; CT, computed tomography; DAA, direct-acting antiviral; DCV, daclatasvir; Direct acting antiviral; EBR, elbasvir; FIB-4, Fibrosis-4; GLE, glecaprevir; GZR, grazoprevir; Hepatitis C virus; IFN, interferon; LDV, ledipasvir; MRI, magnetic resonance imaging; OBV, ombitasvir; OR, odds ratio; P32del; PI, protease inhibitor; PIB, pibrentasvir; PTV/r, paritaprevir/ritonavir; RAS, resistance-associated substitutions; RBV, ribavirin; Resistance-associated substitution; SOF, sofosbuvir; SVR, sustained virological response; VEL, velpatasvir

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: JHEP Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google